Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ti.\*:(%22Developing Probiotics as Food and Drugs%3A Scientific and Regulatory Challenges%22)

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 226660

  • Page / 9067
Export

Selection :

  • and

Developing Probiotics as Food and Drugs: Scientific and Regulatory ChallengesHIBBERD, Patricia L; HOFFMAN, Freddie Ann; HEIMBACH, James T et al.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, 101 p., SUP2Conference Proceedings

Mechanisms of Action of ProbioticsWALKER, W. Allan.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S87-S91, SUP2Conference Paper

Probiotics in the United StatesVANDERHOOF, Jon A; YOUNG, Rosemary.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S67-S72, SUP2Conference Paper

The Safety of ProbioticsSNYDMAN, David R.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S104-S111, SUP2Conference Paper

Development of Probiotics as Biologic DrugsHOFFMAN, Freddie Ann.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S125-S127, SUP2Conference Paper

Product Development of Probiotics as Biological DrugsSUTTON, Ann.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S128-S132, SUP2Conference Paper

Current Marketplace for Probiotics : A Japanese PerspectiveAMAGASE, Harunobu.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S73-S75, SUP2Conference Paper

Probiotics : Definition, Sources, Selection, and UsesSANDERS, Mary Ellen.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S58-S61, SUP2Conference Paper

Environmental Assessment Requirements for Live Biological DrugsSUTTON, Ann.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S112-S114, SUP2Conference Paper

US Food and Drug Administration Regulations Governing Label Claims for Food Products, Including ProbioticsSALDANHA, Leila G.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S119-S121, SUP2Conference Paper

Health-Benefit Claims for Probiotic ProductsHEIMBACH, James T.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S122-S124, SUP2Conference Paper

Preclinical Testing in the Development of Probiotics : A Regulatory Perspective with Bacillus Strains as an ExampleSOROKULOVA, Iryna.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S92-S95, SUP2Conference Paper

Impact of the Intestinal Microbiota on the Development of Mucosal DefenseGASKINS, H. Rex; CROIX, Jennifer A; NAKAMURA, Noriko et al.Clinical infectious diseases. 2008, Vol 46, issn 1058-4838, S80-S86, SUP2Conference Paper

Recombinant Dairy Starters, Probiotics, and Prebiotics: Scientific, Technological, and Regulatory ChallengesDELCOUR, J; DE VUYST, L; SHORTT, C et al.International dairy journal. 1999, Vol 9, Num 1, issn 0958-6946, 82 p.Conference Proceedings

Probiotics : mechanisms and established effectsOUWEHAND, A. C; KIRJAVAINEN, P. V; SHORTT, C et al.International dairy journal. 1999, Vol 9, Num 1, pp 43-52, issn 0958-6946Conference Paper

Prebiotics, probiotics and human gut microbiologyFOOKS, L. J; FULLER, R; GIBSON, G. R et al.International dairy journal. 1999, Vol 9, Num 1, pp 53-61, issn 0958-6946Conference Paper

Challenges in developing effective probiotic functional foods, including scientific and regulatory considerations : Dairy nutrition for a healthy futureAIMUTIS, W. R.Bulletin - International Dairy Federation. 2001, Num 363, pp 30-38, issn 0259-8434Article

Interactions between commensal bacteria and mucosal immunocompetent cellsBLUM, S; DELNESTE, Y; ALVAREZ, S et al.International dairy journal. 1999, Vol 9, Num 1, pp 63-68, issn 0958-6946Conference Paper

New regulatory trends for probioticsBIANCO PREVOT, Michela.Journal of clinical gastroenterology. 2004, Vol 38, Num 6, pp 61-63, issn 0192-0790, 3 p., SUPConference Paper

Biosafety aspects of genetically modified lactic acid bacteria in EU legislationLINDGREN, S.International dairy journal. 1999, Vol 9, Num 1, pp 37-41, issn 0958-6946Conference Paper

Lactic acid bacteria with health claims-interactions and interference with gastrointestinal floraMATTILA-SANDHOLM, T; MÄTTÖ, J; SAARELA, M et al.International dairy journal. 1999, Vol 9, Num 1, pp 25-35, issn 0958-6946Conference Paper

Recent progress on research and applications of non-digestible galacto-oligosaccharidesSAKO, T; MATSUMOTO, K; TANAKA, R et al.International dairy journal. 1999, Vol 9, Num 1, pp 69-80, issn 0958-6946Conference Paper

The Regulatory Challenge of Food Allergens : Advances in Food Allergen DetectionGENDEL, Steven M.Journal of agricultural and food chemistry (Print). 2013, Vol 61, Num 24, pp 5634-5637, issn 0021-8561, 4 p.Conference Paper

Industrial applications of genetically modified microorganisms : Gene technology at Chr. Hansen A/SHENRIKSEN, C. M; NILSSON, D; HANSEN, S et al.International dairy journal. 1999, Vol 9, Num 1, pp 17-23, issn 0958-6946Conference Paper

Probiotics in aquaculture : Challenges and outlookWANG, Yan-Bo; LI, Jian-Rong; JUNDA LIN et al.Aquaculture (Amsterdam). 2008, Vol 281, Num 1-4, pp 1-4, issn 0044-8486, 4 p.Article

  • Page / 9067